74
Participants
Start Date
December 15, 2017
Primary Completion Date
October 14, 2019
Study Completion Date
October 14, 2019
Nivolumab
Specified dose on specified day
Cetuximab
Specified dose on specified day
Cisplatin
Specified dose on specified day
Radiotherapy
Specified dose on specified day
Local Institution, Tainan City
Local Institution, Nice
Monter Cancer Center - Center for Advanced Medicine Location, Lake Success
Local Institution, Marseille
Upmc- Hillman Cancer Center, Pittsburgh
Local Institution, A Coruña
Eastern Regional Medical Center, Philadelphia
Inova Health System, Falls Church
Local Institution, Madrid
Local Institution, Majadahonda
Local Institution, Cheongju-si
Local Institution, Madrid
CTCA Southeastern Region, Newnan
Winship Cancer Insitute, Emory Crawford Long Hospital, Atlanta
Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital, Thomasville
Orlando Health, Inc, Orlando
Local Institution, Izmir
Pinnacle Research Group, Llc, Anniston
Local Institution, Grenoble
Local Institution, Taichung
Local Institution, Taichung
Local Institution, Valencia
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Local Institution, Ravenna
Local Institution, Lucca
Local Institution, Jeollanam-do
Midwestern Regional medical Center, Zion
University of Kansas Cancer Center, Westwood
The University of Texas MD Anderson Cancer Center-merge, Houston
Cancer Treatment Centers of Phoneix, Goodyear
UCLA Health, Los Angeles
Cancer Care - Torrance Memorial Physician Network, Redondo Beach
HHP Hematology & Oncology Bremerton, Bremerton
Local Institution, Moscow
Local Institution, Yekaterinburg
Local Institution, Isehara
Local Institution, Kashiwa-shi
Local Institution, Tsukuba
Local Institution, Nagoya
Local Institution, Osaka
Local Institution, Osaka-sayama-shi
Local Institution, Kobe
Local Institution, Akashi-shi
Local Institution, Fukuoka
University of Arizona Cancer Center, Tucson
Cancer Center of Central Connecticut, Plainville
Nebraska Methodist Hospital, Omaha
St. Joseph Regional Cancer Center, Bryan
Local Institution, Matsuyama
Local Institution, Natori-shi
Local Institution, Bunkyo-ku
Local Institution, Gdynia
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY